查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726160

药物传输市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区和细分市场预测，2025 年至 2030 年

Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10个工作天内

价格

药物输送市场的成长与趋势

根据 Grand View Research, Inc. 的新报告，全球药物输送设备市场预计到 2030 年将达到 6,674 亿美元，2025 年至 2030 年期间的复合年增长率为 7.5%。

预计未来几年癌症、神经系统疾病、糖尿病和其他感染疾病的发生率不断上升将推动药物传输装置的采用。此外，眼科、神经病学、肿瘤学等各种应用领域的产品推出不断增加预计将推动市场成长。此外，穿戴式药物输送设备在居家医疗环境中的日益普及也有望推动市场的发展。

水凝胶是突出的药物传递载体之一，包括超分子水凝胶、DNA水凝胶、仿生水凝胶、多功能水凝胶和刺激反应水凝胶。这些先进的水凝胶用于多种应用，包括眼科、口腔、肠道、心臟疾病和癌症。类似地，脂质体、奈米粒子和胶束等其他载体也被开发用于各种应用。

市场的主要参与企业正在采用併购、合作和共同开发等各种策略来开发和改进各种应用的药物输送装置。此外，最终用户还与公司伙伴关係购买药物输送设备，用于培训目的和研究。此外，市场参与企业正在签订分销协议以扩大其产品的覆盖范围。因此，预计预测期内公司之间的合作将推动市场成长。

药物输送市场报告重点

  • 受气喘治疗需求的推动，吸入器领域将在 2024 年占据 23.9% 的市场份额，引领市场。然而，传统的定量吸入器对温室气体排放贡献巨大。
  • 2024 年，糖尿病药物输送装置领域占据市场主导地位，份额为 21.1%。
  • 受外科手术和预防程序需求不断增长的推动，预计到 2024 年医院部门将占据最大的市场占有率份额，达到 29.0%。
  • 北美药物输送设备市场将主导全球市场，到 2024 年收入份额将达到 32.4%。

目录

第一章调查方法与范围

第二章执行摘要

第三章药物输送装置市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 药物输送装置市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章 药物输送装置市场：依产品分類的估算与趋势分析

  • 细分仪表板
  • 药物输送装置市场：产品差异分析
  • 药物输送装置市场：产品展望
  • 2018-2030年市场规模、预测及趋势分析
  • 吸入器
  • 注射装置
  • 植入
  • 局部配送系统
  • 口服给药系统
  • 眼科输送系统
  • 喷雾器
  • 经皮吸收贴片
  • 点滴帮浦

第五章药物输送装置市场：按应用的估计和趋势分析

  • 细分仪表板
  • 药物输送装置市场：应用趋势分析
  • 药物输送装置市场：应用展望
  • 2018-2030年市场规模、预测及趋势分析
  • 肿瘤学
  • 感染疾病
  • 呼吸系统疾病
  • 糖尿病
  • 心血管疾病
  • 自体免疫疾病
  • 中枢神经系统疾病
  • 其他的

第六章药物输送装置市场：最终用途、估计与趋势分析

  • 细分仪表板
  • 药物输送设备市场：最终用途差异分析
  • 药物输送设备市场：依最终用途分類的展望
  • 2018-2030年市场规模、预测及趋势分析
  • 医院
  • 诊断中心
  • 门诊手术中心/诊所
  • 居家照护
  • 其他的

第七章药物输送装置市场：区域、估计与趋势分析

  • 区域仪表板
  • 区域药物输送装置市场波动分析
  • 药物输送装置市场：按分销管道和最终用途分類的区域评估和趋势分析
  • 2018-2030年市场规模、预测及趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
    • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 市场参与企业分类
  • 主要企业简介
    • Gerresheimer AG
    • WL Gore & Associates, Inc.
    • Abbott
    • Terumo Medical Corporation
    • Stryker
    • Medtronic
    • Boston Scientific Corporation
    • Novartis AG
    • Becton, Dickinson and Company
    • Teleflex Incorporated
Product Code: GVR-4-68038-435-2

Drug Delivery Devices Market Growth & Trends:

The global drug delivery devices market size is expected to reach USD 667.4 billion by 2030, registering a CAGR of 7.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Growing prevalence of cancer, neurological disorders, diabetes, and other infectious diseases is expected to drive the adoption of drug delivery devices in the coming years. In addition, increasing product launches for various applications such as ophthalmology, neurology, and oncology are also expected to propel the market growth. Growing adoption of wearable drug delivery devices for its usage in home-care settings is also expected to drive the market.

Hydrogel is one of the prominent drug delivery vehicles and includes supramolecular hydrogels, DNA hydrogels, bio-inspired hydrogels, multi-functional and stimuli-responsive hydrogels. These advanced hydrogels are used for various applications such as ophthalmic, oral, intestinal, cardiac illness, and cancer. Similarly, other vehicles such as liposomes, nanoparticles, and micelle are also being developed for various applications.

Key players present in the market are adopting various strategies such as mergers and acquisitions, partnership, and collaborations to develop and improve drug delivery devices for various applications. Moreover, end-users are also forming partnerships with companies to acquire drug delivery devices for training purpose and research studies. In addition, market players are also forming distribution agreement to expand the reach of their products. Therefore, alliances made by the players are expected to drive the market growth during the forecast period.

Drug Delivery Devices Market Report Highlights:

  • The inhalers segment leads the market with a share of 23.9% in 2024, driven by the demand for asthma treatment. However, conventional metered-dose inhalers contribute significantly to greenhouse gas emissions.
  • The drug delivery devices segment for diabetes dominated the market in 2024 with a share of 21.1%.
  • The hospitals segment held the largest market share in 2024 with a share of 29.0%, driven by the rising demand for surgical interventions and preventive procedures.
  • The North America drug delivery devices market dominated the overall global market and accounted for the 32.4% revenue share in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.21. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Drug Delivery Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Growing demand for novel drug delivery devices
      • 3.2.1.2. Increasing prevalence of chronic diseases
      • 3.2.1.3. Technological advancement in drug delivery devices
      • 3.2.1.4. Growing strategic alliances for drug delivery devices
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Challenges associated with various routes of drug delivery devices
  • 3.3. Drug Delivery Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Drug Delivery Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Drug Delivery Devices Market: Product Movement Analysis
  • 4.3. Drug Delivery Devices Market by Product Outlook (USD Billion)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Inhalers
    • 4.5.1. Inhalers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.1. Metered-dose inhalers (MDIs)
        • 4.5.1.1.1. Metered-dose inhalers (MDIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.2. Dry powder inhalers (DPIs)
        • 4.5.1.2.1. Dry powder inhalers (DPIs) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.5.1.3. Others
        • 4.5.1.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.6. Injection Devices
    • 4.6.1. Injection Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.1. Prefilled Syringes
        • 4.6.1.1.1. Prefilled Syringes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.2. Auto-injectors
        • 4.6.1.2.1. Auto-injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.3. Pen Injectors
        • 4.6.1.3.1. Pen Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.4. Needle-free Injectors
        • 4.6.1.4.1. Needle-free Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.6.1.5. Wearable Injectors
        • 4.6.1.5.1. Wearable Injectors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.7. Implants
    • 4.7.1. Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.1. Contraceptive Implants
        • 4.7.1.1.1. Contraceptive Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.2. Drug-eluting Stents
        • 4.7.1.2.1. Drug-eluting Stents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.7.1.3. Biodegradable Implants
        • 4.7.1.3.1. Biodegradable Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.8. Topical Delivery System
    • 4.8.1. Topical Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.1. Creams
        • 4.8.1.1.1. Creams Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.2. Gels
        • 4.8.1.2.1. Gels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.8.1.3. Ointments
        • 4.8.1.3.1. Ointments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.9. Oral Delivery System
    • 4.9.1. Oral Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.1. Controlled-release Tablets and Capsules
        • 4.9.1.1.1. Controlled-release Tablets and Capsules Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
      • 4.9.1.2. Buccal and Sublingual Tablets
        • 4.9.1.2.1. Buccal and Sublingual Tablets Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.10. Occular Delivery System
    • 4.10.1. Occular Delivery System Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.11. Nebulizers
    • 4.11.1. Nebulizers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.12. Transdermal Patches
    • 4.12.1. Transdermal Patches Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.13. Infusion Pumps
    • 4.13.1. Infusion Pumps Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Drug Delivery Devices Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Drug Delivery Devices Market: Application Movement Analysis
  • 5.3. Drug Delivery Devices Market by Application Outlook (USD Billion)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Oncology
    • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. Infectious Diseases
    • 5.6.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Respiratory Diseases
    • 5.7.1. Respiratory Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. Diabetes
    • 5.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Cardiovascular Diseases
    • 5.9.1. Cardiovascular Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.10. Autoimmune Diseases
    • 5.10.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.11. Central Nervous System Disorders
    • 5.11.1. Central Nervous System Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.12. Others
    • 5.12.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Drug Delivery Devices Market: End-use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Drug Delivery Devices Market: End-use Movement Analysis
  • 6.3. Drug Delivery Devices Market by End-use Outlook (USD Billion)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Hospitals
    • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.6. Diagnostic Centers
    • 6.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.7. Ambulatory Surgery Centers/Clinics
    • 6.7.1. Ambulatory Surgery Centers/Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.8. Home Care Settings
    • 6.8.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.9. Others
    • 6.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Drug Delivery Devices Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Regional Drug Delivery Devices Market Movement Analysis
  • 7.3. Drug Delivery Devices Market: Regional Estimates & Trend Analysis by Distribution Channel & End-use
  • 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 7.5. North America
    • 7.5.1. North America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.2. U.S.
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. Regulatory Framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. U.S. Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.3. Canada
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Regulatory Framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Canada Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. Regulatory Framework
      • 7.5.4.4. Reimbursement scenario
      • 7.5.4.5. Mexico Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.5. Europe
    • 7.5.6. Europe Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.7. UK
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Regulatory Framework
      • 7.5.7.4. Reimbursement scenario
      • 7.5.7.5. UK Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.8. Germany
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Regulatory Framework
      • 7.5.8.4. Reimbursement scenario
      • 7.5.8.5. Germany Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.9. France
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Regulatory Framework
      • 7.5.9.4. Reimbursement scenario
      • 7.5.9.5. France Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.10. Italy
      • 7.5.10.1. Key Country Dynamics
      • 7.5.10.2. Competitive Scenario
      • 7.5.10.3. Regulatory Framework
      • 7.5.10.4. Reimbursement scenario
      • 7.5.10.5. Italy Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.11. Spain
      • 7.5.11.1. Key Country Dynamics
      • 7.5.11.2. Competitive Scenario
      • 7.5.11.3. Regulatory Framework
      • 7.5.11.4. Reimbursement scenario
      • 7.5.11.5. Spain Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.12. Denmark
      • 7.5.12.1. Key Country Dynamics
      • 7.5.12.2. Competitive Scenario
      • 7.5.12.3. Regulatory Framework
      • 7.5.12.4. Reimbursement scenario
      • 7.5.12.5. Denmark Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.13. Sweden
      • 7.5.13.1. Key Country Dynamics
      • 7.5.13.2. Competitive Scenario
      • 7.5.13.3. Regulatory Framework
      • 7.5.13.4. Reimbursement scenario
      • 7.5.13.5. Sweden Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.5.14. Norway
      • 7.5.14.1. Key Country Dynamics
      • 7.5.14.2. Competitive Scenario
      • 7.5.14.3. Regulatory Framework
      • 7.5.14.4. Reimbursement scenario
      • 7.5.14.5. Norway Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Regulatory Framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Japan Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. Regulatory Framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. China Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. Regulatory Framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. India Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.5. South Korea
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Regulatory Framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. South Korea Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.6. Australia
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Regulatory Framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Australia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.6.7. Thailand
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. Regulatory Framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Thailand Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.7. Latin America
    • 7.7.1. Latin America Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Regulatory Framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. Brazil Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Regulatory Framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. Argentina Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.8. Middle East & Africa
    • 7.8.1. Middle East & Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.2. South Africa
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Regulatory Framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. South Africa Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. Regulatory Framework
      • 7.8.3.4. Reimbursement scenario
      • 7.8.3.5. Saudi Arabia Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. Regulatory Framework
      • 7.8.4.4. Reimbursement scenario
      • 7.8.4.5. UAE Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Regulatory Framework
      • 7.8.5.4. Reimbursement scenario
      • 7.8.5.5. Kuwait Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Gerresheimer AG
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. W. L. Gore & Associates, Inc.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Abbott
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Terumo Medical Corporation
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Stryker
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Boston Scientific Corporation
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Novartis AG
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Becton, Dickinson and Company
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Teleflex Incorporated
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. North America drug delivery devices market, by country, 2018 - 2030 (USD Billion)
  • Table 4. North America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 5. North America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 6. North America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 7. U.S. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 8. U.S. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 9. U.S. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 10. Canada drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 11. Canada drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 12. Canada drug delivery devices market, by end-use, (USD Billion) 2018 - 2030
  • Table 13. Mexico drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 14. Mexico drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 15. Mexico drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 16. Europe drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 17. Europe drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 18. Europe drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 19. Europe drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 20. Germany drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 21. Germany drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 22. Germany drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 23. U.K. drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 24. U.K. drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 25. U.K. drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 26. France drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 27. France drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 28. France drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 29. Italy drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 30. Italy drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 31. Italy drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 32. Spain drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 33. Spain drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 34. Spain drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 35. Denmark drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 36. Denmark drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 37. Denmark drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 38. Sweden drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 39. Sweden drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 40. Sweden drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 41. Norway drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 42. Norway drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 43. Norway drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 44. APAC drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 45. APAC drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 46. APAC drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 47. APAC drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 48. China drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 49. China drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 50. China drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 51. Japan drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 52. Japan drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 53. Japan drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 54. India drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 55. India drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 56. India drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 57. Thailand drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 58. Thailand drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 59. Thailand drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 60. South Korea drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 61. South Korea drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 62. South Korea drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 63. Australia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 64. Australia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 65. Australia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 66. Latin America drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 67. Latin America drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 68. Latin America drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 69. Latin America drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 70. Brazil drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 71. Brazil drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 72. Brazil drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 73. Argentina drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 74. Argentina drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 75. Argentina drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 76. Middle East and Africa drug delivery devices market, by region, 2018 - 2030 (USD Billion)
  • Table 77. Middle East and Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 78. Middle East and Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 79. Middle East and Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 80. South Africa drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 81. South Africa drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 82. South Africa drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 83. Saudi Arabia drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 84. Saudi Arabia drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 85. Saudi Arabia drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 86. UAE drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 87. UAE drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 88. UAE drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)
  • Table 89. Kuwait drug delivery devices market, by product, 2018 - 2030 (USD Billion)
  • Table 90. Kuwait drug delivery devices market, by application, 2018 - 2030 (USD Billion)
  • Table 91. Kuwait drug delivery devices market, by end-use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Drug delivery devices market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Drug delivery devices market, Product outlook key takeaways (USD Billion)
  • Fig. 12 Drug delivery devices market Product movement analysis 2023 & 2030 (USD Billion)
  • Fig. 13 Inhalers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 14 Metered-dose inhalers (MDIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 15 Dry powder inhalers (DPIs) market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 16 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 17 Injection devices market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 18 Prefilled syringes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 19 Auto-injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 20 Pen injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 21 Needle-free injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 22 Wearable injectors market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 23 Implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 24 Contraceptive implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 25 Drug-eluting stents market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 26 Biodegradable implants market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 27 Topical delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 28 Creams market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 29 Gels market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 30 Ointments market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 31 Oral delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 32 Controlled-release tablets and capsules market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 33 Buccal and sublingual tablets market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 34 Occular delivery system market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 35 Nebulizers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 36 Transdermal patches market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 37 Infusion pumps market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 38 Drug delivery devices market, application outlook key takeaways (USD Billion)
  • Fig. 39 Drug delivery devices market application movement analysis 2023 & 2030 (USD Billion)
  • Fig. 40 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 41 Infectious diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 42 Respiratory diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 43 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 44 Cardiovascular diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 45 Autoimmune diseases market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 46 Central nervous system disorders market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 47 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 48 Drug delivery devices market, end use outlook key takeaways (USD Billion)
  • Fig. 49 Drug delivery devices market, end use movement analysis 2023 & 2030 (USD Billion)
  • Fig. 50 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 51 Diagnostic centers market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 52 Ambulatory surgery centers/clinics market, application outlook key takeaways (USD Billion)
  • Fig. 53 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 54 Others market revenue estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 55 Drug delivery devices market: Regional key takeaways (USD Billion)
  • Fig. 56 Drug delivery devices market regional outlook, 2023 & 2030 (USD Billion)
  • Fig. 57 North America drug delivery devices estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 58 US drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 59 Canada drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 60 Mexico drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 61 Europe drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 62 UK drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 63 Germany drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 64 France drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 65 Spain drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 66 Italy drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 67 Sweden drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 68 Norway drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 69 Denmark drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 70 Asia Pacific drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 71 China drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 72 Japan drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 73 India drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 74 South Korea drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 75 Australia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 76 Thailand drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 77 Latin America drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 78 Brazil drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 79 Argentina drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 80 Middle East and Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 81 South Africa drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 82 Saudi Arabia drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 83 UAE drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 84 Kuwait drug delivery devices market estimates and forecasts, 2018 - 2030 (USD Billion)
  • Fig. 85 List of key emerging company's/distribution channel disruptors/innovators